Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P2DU
|
|||
| Former ID |
DNC003871
|
|||
| Drug Name |
Prodipine
|
|||
| Synonyms |
Prodipine; 1-Isopropyl-4,4-diphenylpiperidine; UNII-51567MYG7V; 31314-38-2; CHEMBL277382; 51567MYG7V; Prodipinum; Prodipin; Prodipina; Prodipine [INN]; Prodipinum [INN-Latin]; Prodipina [INN-Spanish]; AC1L23XQ; SCHEMBL148420; DTXSID20185247; CFOOTBBXHJHHMT-UHFFFAOYSA-N; 1-i-propyl-4,4-diphenylpiperidine; ZINC1482151; BDBM50047020; 4,4-diphenyl-1-propan-2-ylpiperidine; 1-Isopropyl-4,4-diphenyl-piperidine (prodipine)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H25N
|
|||
| Canonical SMILES |
CC(C)N1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C20H25N/c1-17(2)21-15-13-20(14-16-21,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17H,13-16H2,1-2H3
|
|||
| InChIKey |
CFOOTBBXHJHHMT-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 31314-38-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Debrisoquine 4-hydroxylase (CYP2D6) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Metabolism of xenobiotics by cytochrome P450 | |||
| Drug metabolism - cytochrome P450 | ||||
| Serotonergic synapse | ||||
| Reactome | Xenobiotics | |||
| WikiPathways | Metapathway biotransformation | |||
| Tamoxifen metabolism | ||||
| Oxidation by Cytochrome P450 | ||||
| Vitamin D Receptor Pathway | ||||
| Aripiprazole Metabolic Pathway | ||||
| Fatty Acid Omega Oxidation | ||||
| Codeine and Morphine Metabolism | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. J Med Chem. 1993 Apr 30;36(9):1136-45. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.